34541-75-8

Basic information

• Product Name: 2-Butenoic acid, 4-phenyl-, methyl ester, (2E)-
• CAS NO: 34541-75-8
• Molecular Formula: C11H12O2
• Molecular Weight: 176.215
• Mol File: 34541-75-8.mol
• Article Data: 40

Chemical Properties

• CAS DataBase Reference: 2-Butenoic acid, 4-phenyl-, methyl ester, (2E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Butenoic acid, 4-phenyl-, methyl ester, (2E)-(34541-75-8)
• EPA Substance Registry System: 2-Butenoic acid, 4-phenyl-, methyl ester, (2E)-(34541-75-8)

Safety Data

• Hazardous Substances Data: 34541-75-8(Hazardous Substances Data)

Upstream product

• 3724-55-8 methyl but-3-enoate 
• 62-38-4 phenylmercuric acetate 
• 1067-74-9 Methyl diethylphosphonoacetate 
• 122-78-1 phenylacetaldehyde 
• 21204-67-1 methyl (triphenylphosphoranylidene)acetate 
• 100-39-0 benzyl bromide 
• 292638-85-8 acrylic acid methyl ester 
• 100-44-7 benzyl chloride 
• 300-57-2 allylbenzene 
• 186581-53-3 diazomethane 
• 60341-39-1 (E)-4-phenylbut-2-enoic acid 
• 1117-71-1 methyl-4-bromo-2-butenoate 
• 98-80-6 phenylboronic acid 
• 4406-72-8 2-phenyl[1,3,2]dioxaborolane 

Downstream Products

• 75414-69-6 methyl threo-2,3-dihydroxy-4-phenylbutanoate 
• 73845-40-6 methyl trans-2,3-epoxy-4-phenylbutanoate 
• 91478-80-7 dimethyl 3-benzylglutarate 
• 35289-35-1 3-Benzyl-pentanoic acid methyl ester 
• 260354-41-4 (4R,5S)-5-Benzyl-2,2-dimethyl-[1,3]dioxolane-4-carbaldehyde 
• 351340-33-5 methyl (4R,5S)-5-benzyl-2,2-dimethyl-1,3-dioxolane-4-carboxylate 
• 351340-70-0 Benzyl-[1-((4S,5S)-5-benzyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-meth-(E)-ylidene]-amine 
• 351340-36-8 (2R,3S)-2,3-Bis-(tert-butyl-dimethyl-silanyloxy)-4-phenyl-butyric acid methyl ester 
• 351340-73-3 Benzyl-[(2S,3S)-2,3-bis-(tert-butyl-dimethyl-silanyloxy)-4-phenyl-but-(E)-ylidene]-amine 
• 59554-14-2 (±)-(4R,5S)-4-benzyl-2-oxooxazolidine-5-carboxylic acid 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6

The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.

Visible-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis

Olefin metathesis is now one of the most efficient ways to create new carbon-carbon bonds. While most efforts focused on the development of ever-more efficient catalysts, a particular attention has recently been devoted to developing latent metathesis cat